Log inSign up

Cara Therapeutics

3 followers

‌

Cara Therapeutics is an early commercial-stage biopharmaceutical company focused on developing and commercializing new chemical entities designed to alleviate pruritus by selectively targeting peripheral kappa opioid receptors, or KORs.

Industries

Biotechnology

Headquarters

Stamford, United States

Employees

51-200

Links

Org chart

Christopher Posner
CEO, President & Director

Christopher Posner

Collapse
Ryan Maynard
Chief Financial Officer
Frédérique Menzaghi
Chief Scientific Officer, SVP Research & Development
Jo Goncalves
Chief Medical Officer
Scott Terrillion
General Counsel, Secretary & Chief Compliance Officer
Eric Vandal
SVP, Commercial
Beth Weinberg
SVP, Regulatory Affairs & QA
Stephen O’Connor
Vice President CMC Technical Operations

Teams

+7

Research and Development

10 members

DR
KM
KN
+4

Clinical Operations

7 members

+4

Leadership Team

7 members

JC

Regulatory and Quality Assurance Team

2 members

RM

Finance and Accounting

3 members

Similar companies

Relay Therapeutics

1 follower

Eikon Therapeutics

1 follower

Thermo Fisher Scientific

166 followers

Formation Bio

2 followers

Regeneron

94 followers

Agilent Technologies

63 followers

Alexion Pharmaceuticals

34 followers

Charles River Laboratories

11 followers

Cytiva

10 followers

FirstWord Group

2 followers

Merck

216 followers

Explore companies